Pain Relieving Petro Carbo

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Pain Relieving Petro Carbo
Generic name: PHENOL
Manufacturer: J.R. Watkins, LLC.
Product type: HUMAN OTC DRUG
SPL set ID: 050cf17d-3be7-45b9-8524-ad82af309a0e
SPL ID: 10bd16c6-e569-4a2c-e063-6294a90aa763
Version: 4
Effective date: 2024-02-06
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:24:00

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Pain Relieving Petro Carbo	openfda.brand_name
generic name		PHENOL	openfda.generic_name
manufacturer name		J.R. Watkins, LLC.	openfda.manufacturer_name
ndc	package	72342-060-21	openfda.package_ndc
ndc	product	72342-060	openfda.product_ndc
ndc11	package	72342006021	derived:openfda.package_ndc
rxcui		2198796	openfda.rxcui
spl id		10bd16c6-e569-4a2c-e063-6294a90aa763	id
spl set id		050cf17d-3be7-45b9-8524-ad82af309a0e	set_id
unii		339NCG44TV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes Discontinue use and consult a physician if symptoms worsen persist for more than 7 days clear up the recur within a few days Do not apply over large areas of the body bandage Keep out of reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.